Skip to content
    Auliv Health Auliv HealthAuliv Health
    • Weight Loss
    • Hormone Replacement
    Aulie-Logo_e6257e58-ee10-4005-83d9-d36eafa0f961
    2024 © All rights reserved, AulivHealth Inc.
    Terms of Service

    Privacy Policy /HIPPA

    Contact Us

    Call us: (424) 999-5352
    Email: hello@aulivhealth.com   

    872 W. 16th Street
    Newport Beach CA 92663
    The trademarks, service marks, trade names (Wegovy®, Ozempic®), and products displayed on this Internet site are protected and belong to their respective owners.

    * After 68 weeks, participants administering once-weekly semaglutide treatment experienced an average of 15% reduction in body weight. The mean change in body weight from baseline to week 68 was −14.9% in the semaglutide group as compared with −2.4% with placebo. (Source) Results may vary based on starting weight and program adherence. Medication prescriptions are at the discretion of medical providers and may not be suitable for everyone. Consult a healthcare professional before starting any weight loss program.

    Safety info: GLP-1 medications are used to treat obesity or overweight (with weight-related problems), along with diet and exercise. They may have serious side effects, including possible thyroid tumors. Do not use if you or your family have a history of a type of thyroid cancer called MTC or MEN 2.
    • Choosing a selection results in a full page refresh.